Announcements

The Foundation’s Role in Advancing Medical Product Development in the United States
Read More
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Read More
Call for Nominations for the 2026 Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.
Read More
More Announcements

Coverage

Spruce Biosciences at H.C. Wainwright: BLA Path Comes into Focus
The regulatory picture changed in February 2024, when the FDA held a Reagan-Udall Foundation forum on neuronopathic mucopolysaccharidoses.
Read More
Why CDC Opioid Guidelines Get the Overdose Data Wrong
On Wednesday, September 9, 2026, the author spoke briefly at a hybrid conference conducted by the Reagan-Udall Foundation for the U.S. Food and Drug Administration in Washington, D.C.
Read More
This Week at FDA: Pregnancy Exposure Registries, PRV Fee Rates, and More
The Reagan-Udall Foundation for the FDA and FDA are also co-hosting a hybrid meeting on 16 October to discuss where the patient voice is needed in the rare disease product development timeline, its impact, and opportunities for patients to engage in the…
Read More
More Coverage